569 related articles for article (PubMed ID: 17368897)
1. Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.
Gomez L; Hack MD; Wu J; Wiener JJ; Venkatesan H; Santillán A; Pippel DJ; Mani N; Morrow BJ; Motley ST; Shaw KJ; Wolin R; Grice CA; Jones TK
Bioorg Med Chem Lett; 2007 May; 17(10):2723-7. PubMed ID: 17368897
[TBL] [Abstract][Full Text] [Related]
2. Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.
Wiener JJ; Gomez L; Venkatesan H; Santillán A; Allison BD; Schwarz KL; Shinde S; Tang L; Hack MD; Morrow BJ; Motley ST; Goldschmidt RM; Shaw KJ; Jones TK; Grice CA
Bioorg Med Chem Lett; 2007 May; 17(10):2718-22. PubMed ID: 17382544
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives.
Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Iwai N; Hiyama Y; Suzuki K; Ito H; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
J Med Chem; 2004 Jul; 47(14):3693-6. PubMed ID: 15214796
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR of novel conformationally-restricted oxazolidinones possessing gram-positive and fastidious gram-negative antibacterial activity. Part 1: Substituted pyrazoles.
Boyer FE; Vara Prasad JV; Choy AL; Chupak L; Dermyer MR; Ding Q; Huband MD; Jiao W; Kaneko T; Khlebnikov V; Kim JY; Lall MS; Maiti SN; Romero K; Wu X
Bioorg Med Chem Lett; 2007 Aug; 17(16):4694-8. PubMed ID: 17590334
[TBL] [Abstract][Full Text] [Related]
7. Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity.
Tanitame A; Oyamada Y; Ofuji K; Suzuki K; Ito H; Kawasaki M; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2863-6. PubMed ID: 15125948
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.
Li Q; Chu DT; Claiborne A; Cooper CS; Lee CM; Raye K; Berst KB; Donner P; Wang W; Hasvold L; Fung A; Ma Z; Tufano M; Flamm R; Shen LL; Baranowski J; Nilius A; Alder J; Meulbroek J; Marsh K; Crowell D; Hui Y; Seif L; Melcher LM; Plattner JJ
J Med Chem; 1996 Aug; 39(16):3070-88. PubMed ID: 8759628
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antibacterial activity and structure-activity relationships of N-substituted 4-diazo-pyrazole-5-carboxamides. 2.
Baraldi PG; Cacciari B; Leoni A; Recanatini M; Roberti M; Rossi M; Manfredini S; Periotto V; Simoni D
Farmaco; 1991 Nov; 46(11):1337-50. PubMed ID: 1811619
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of a novel series of DNA gyrase inhibitors: 5-[(E)-2-arylvinyl]pyrazoles.
Tanitame A; Oyamada Y; Ofuji K; Terauchi H; Kawasaki M; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2005 Oct; 15(19):4299-303. PubMed ID: 16087337
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors.
Tran TP; Ellsworth EL; Sanchez JP; Watson BM; Stier MA; Showalter HD; Domagala JM; Shapiro MA; Joannides ET; Gracheck SJ; Nguyen DQ; Bird P; Yip J; Sharadendu A; Ha C; Ramezani S; Wu X; Singh R
Bioorg Med Chem Lett; 2007 Mar; 17(5):1312-20. PubMed ID: 17196390
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial and antifungal activities of new pyrazolo[3,4-d]pyridazin derivatives.
Akbas E; Berber I
Eur J Med Chem; 2005 Apr; 40(4):401-5. PubMed ID: 15804539
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anti-microbial activity of 1H-pyrazole carboxylates.
Sridhar R; Perumal PT; Etti S; Shanmugam G; Ponnuswamy MN; Prabavathy VR; Mathivanan N
Bioorg Med Chem Lett; 2004 Dec; 14(24):6035-40. PubMed ID: 15546724
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and structure-activity relationship studies of new phenolic DNA gyrase inhibitors.
Lübbers T; Angehrn P; Gmünder H; Herzig S
Bioorg Med Chem Lett; 2007 Aug; 17(16):4708-14. PubMed ID: 17632001
[TBL] [Abstract][Full Text] [Related]
15. Novel pyrazolo[3,4-d]pyrimidine-based inhibitors of Staphlococcus aureus DNA polymerase III: design, synthesis, and biological evaluation.
Ali A; Taylor GE; Ellsworth K; Harris G; Painter R; Silver LL; Young K
J Med Chem; 2003 May; 46(10):1824-30. PubMed ID: 12723946
[TBL] [Abstract][Full Text] [Related]
16. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.
Mitscher LA
Chem Rev; 2005 Feb; 105(2):559-92. PubMed ID: 15700957
[No Abstract] [Full Text] [Related]
17. Synthesis and antibacterial activity of a new series of 3-[3-(substituted phenyl)-1-isonicotinoyl-1H-pyrazol-5-yl]-2H-chromen-2-one derivatives.
Aragade P; Maddi V; Khode S; Palkar M; Ronad P; Mamledesai S; Satyanarayana D
Arch Pharm (Weinheim); 2009 Jun; 342(6):361-6. PubMed ID: 19475595
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
Lv PC; Wang KR; Yang Y; Mao WJ; Chen J; Xiong J; Zhu HL
Bioorg Med Chem Lett; 2009 Dec; 19(23):6750-4. PubMed ID: 19836235
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 1,3-diaryl pyrazole derivatives bearing rhodanine-3-fatty acid moieties as potential antibacterial agents.
Xu LL; Zheng CJ; Sun LP; Miao J; Piao HR
Eur J Med Chem; 2012 Feb; 48():174-8. PubMed ID: 22192483
[TBL] [Abstract][Full Text] [Related]
20. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R
J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
